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Introduction: Cerebral salt-wasting syndrome is a condition featuring hyponatremia and dehydration caused by
head injury, operation on the brain, subarachnoid hemorrhage, brain tumor and so on. However, there are a few
reports of cerebral salt-wasting syndrome caused by cerebral infarction. We describe a patient with cerebral
infarction who developed cerebral salt-wasting syndrome in the course of hemorrhagic transformation.
Case presentation: A 79-year-old Japanese woman with hypertension and arrhythmia was admitted to our hospital
for mild consciousness disturbance, conjugate deviation to right, left unilateral spatial neglect and left hemiparesis.
Magnetic resonance imaging revealed a broad ischemic change in right middle cerebral arterial territory. She was
diagnosed as cardiogenic cerebral embolism because atrial fibrillation was detected on electrocardiogram on
admission. She showed hyponatremia accompanied by polyuria complicated at the same time with the
development of hemorrhagic transformation on day 14 after admission. Based on her hypovolemic hyponatremia,
she was evaluated as not having syndrome of inappropriate secretion of antidiuretic hormone but cerebral
salt-wasting syndrome. She fortunately recovered with proper fluid replacement and electrolyte management.
Conclusions: This is a rare case of cerebral infarction and cerebral salt-wasting syndrome in the course of
hemorrhagic transformation. It may be difficult to distinguish cerebral salt-wasting syndrome from syndrome of
inappropriate antidiuretic hormone, however, an accurate assessment is needed to reveal the diagnosis of cerebral
salt-wasting syndrome because the recommended fluid management is opposite in the two conditions.
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It is not rare to encounter hyponatremia during the course
of acute central nervous system (CNS) diseases. In
the literature, hyponatremia complicates about 30% of
subarachnoid hemorrhage cases [1,2] and 16.8% of head
injury cases [3]. Syndrome of inappropriate secretion of
antidiuretic hormone (SIADH) and cerebral salt-wasting
syndrome (CSWS) have been reported as the major causes
of hyponatremia, while the therapeutic policy is essentially
opposite because of a difference in the circulatory blood
volume. Therefore, it is crucial to differentiate SIADH and
CSWS from the clinical viewpoint. There have been many
reports of CSWS following subarachnoid hemorrhage, but
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unless otherwise stated.has been rarely reported. We report the case of a woman
with cerebral infarction who developed CSWS in the
course of hemorrhagic transformation.
Case presentation
A 79-year-old Japanese woman with a past medical his-
tory of hypertension and arrhythmia suddenly developed
left hemiparesis and drowsy state, and was sent to our
emergency room. A neurological examination showed mild
consciousness disturbance, conjugate deviation to right,
mild dysarthria, left unilateral spatial neglect, left facial and
motor weakness, and left sensory disturbance. Magnetic
resonance imaging depicted a large high intensity lesion in
right middle and posterior cerebral arterial territory on
diffusion weighted images, and her right internal carotid
artery was obstructed on magnetic resonance arteriog-
raphy (MRA). Atrial fibrillation was observed on elec-
trocardiogram. No other vascular lesion which may
have caused the disease was noted, suggesting cardiogenicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Changes of cerebral infarction in computed tomography. Slight, broad low density area in the right middle cerebral artery territory
was depicted on day 1, showing the early cerebral infarction. Large low density area with midline shift and high density was depicted on day 15
and day 24, showing hemorrhagic transformation and severe brain edema.
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mal findings including hemoglobin 13.0g/dL, hematocrit
39.8%, sodium (Na) 142mEq/L, blood urea nitrogen
(BUN) 16mg/dL, and creatinine, 0.69mg/dL. In addition
to anti-edema therapy, the continuous intravenous infu-
sion of heparin was initiated on the following day because
no apparent hemorrhage was identified on computed
tomography (CT). No marked change was noted in neuro-
logical signs, and her brain edema tended to improve on
CT. On day 14, her right internal carotid artery became
patent on MRA, and hemorrhage occurred in the infarct
region of her right middle cerebral artery. Thus, heparin
administration was discontinued on the same day.
However, hemorrhage and brain edema expanded on
day 15 (Figure 1), and consciousness disturbance deteri-
orated. Concurrently, in addition to polyuria and hypo-
natremia (Figure 2 and Table 1), features of dehydration
appeared, such as reduction of skin turgor, collapse ofFigure 2 Time course of serum sodium value and urine volume.
Two weeks after admission, hyponatremia and diuresis progressed
following hemorrhagic transformation. The urine volume and
sodium value were normalized with precise fluid and sodium
correction and improvement of hemorrhagic change and edema.the inferior vena cava (IVC), and weight loss. Fluid re-
placement induced only an increase of urine volume and
failed to correct dehydration tendency (input of 3410mL
compared to a total urinary output of 3710mL on day
20). Considering the possibility of diabetes insipidus, a
water deprivation antidiuretic hormone stimulation test
(by inserting 10mcg of desmopressin into a nostril by
using the spray once) was performed on day 28, however,
her urine volume did not decrease. Despite adequate fluid
replacement, she was in negative fluid balance and her
weight had decreased by 4.6%, from 39.2kg to 37.4kg. An
endocrinological examination excluded SIADH because of
hydration features. CSWS was assumed to be a more
probable pathological state, and salt supply was added to
fluid replacement on day 29. Following the alleviation of
hemorrhagic transformation, her excessive urine volume
slowly decreased, and her hyponatremia and dehydration
improved. She was transferred to another rehabilitation
hospital about 2 months after admission.
Discussion
CSWS was reported as a condition of urine volume
increase and excess loss of urinary Na accompanied byTable 1 The transition of biochemical parameters related
to the abnormality of sodium metabolism in the patient
Days from onset
Biochemical data Day 15 Day 25 Day 52
Serum sodium (mEq/L) 134 133 143
Uosm (Osm/kg·H2O) 454 385 266
Posm (Osm/kg·H2O) 279 no data no data
Urinary sodium excretion (mEq/day) 219 239 179
FEUA (%) 26 16 12
FEUA, fractional excretion of uric acid; Posm, plasma osmolality; Uosm,
urine osmolality.
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Hyponatremia is a common complication in CNS diseases,
especially head injury and cerebrovascular disorder, and
has been regarded as SIADH in general. Considering
dehydration associated with hyponatremia, however,
CSWS was more common than SIADH in CNS diseases
as Nelson et al. pointed out [5]. Since then, many cases of
CSWS have been reported, while the pathogenesis of
CSWS has remained unexplained. Some reports showed
that atrial and brain natriuretic peptides (ANP and BNP)
from damaged CNS tissues and abnormality of the sympa-
thetic nervous system might induce CSWS [6-9]. That is,
the increasing natriuretic peptide secretion and catechol-
amine might cause natriuresis via reduced renin secretion
[9-12]. In our case, the level of ANP and BNP continued
to be elevated (BNP 250.2pg/mL, ANP 200pg/mL) after
the improvement of cardiac function.
CSWS is frequently associated with CNS hemorrhagic
diseases, but only a few cases of CSWS in brain infarc-
tion have been reported [11-13]. The previous case re-
ports of cerebral infarction had the characteristics of
severe physical stress including systemic autoimmune
disease, serious infection, and trauma (Table 2) [11,13].
These systemic complications might be more suscep-
tible to developing CSWS than localized involvement
in patients with cerebral infarction. In fact, in our
patient, manifestation of CSWS appeared not in the
early stage but in the advanced stage with hemorrhagic
transformation and excessive edema of cardiogenic
brain infarction.
Whereas SIADH management requires strict fluid
volume restriction, the treatment policy of CSWS is ad-
equate fluid balance control and substitution of sodium
chloride. Distinguishing these conditions may be unex-
pectedly difficult [14] because they show much in com-
mon; they have overlapping clinical and biochemical signs
such as absence of peripheral edema, normal renal and
adrenal function, low serum Na, low serum osmolality,
and high urinary Na. Glycerol and mannitol as hyperos-
molar agents are commonly used for brain edema, making
it difficult to assess the true urinary and plasma volume.
Extracellular volume assessment is a key factor to distin-
guish CSWS from SIADH. Due to a lack of precise assess-
ment of the amount of extracellular fluid, it is necessary to
note clinical dehydration signs such as reduction of turgor,
raised heartbeat, body weight loss and collapsed IVC as
well as laboratory findings including BUN/creatinine ratio.
Furthermore, the persistence of hypouricemia and eleva-
tion of fractional excretion of uric acid (FEUA) even after
the correction of hyponatremia may contribute to dif-
ferentiate CSWS from SIADH as already reported [15].
In our patient, the serum Na level normalized on day
52, but the FEUA was still 10% higher than normal
range (Table 1).Conclusions
We reported a case of CSWS following cerebral infarc-
tion. In patients with severe stroke, disturbances of Na
metabolism are frequent. It is important to investigate
the causes of hyponatremia in patients with stroke, con-
sidering the differential diagnosis of SIADH and CSWS
by assessing the dehydration signs.
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